Laser angioplasty to be used on small vessels:
This article was originally published in Clinica
Spectranetics is to start European sales of a laser angioplasty system for treating small coronary arteries. The Colorado Springs, Colorado-based company has CE-marked its 0.9mm catheter, for use with the CVX-300 excimer laser, and has applied for approval to market the device in the US. The company also recently CE-marked a 2.2mm catheter for laser angioplasty of larger coronary arteries.
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
Stada has appointed a head of digital communications; PGEU elects new chair and vice-chair; and the new UK health claims committee unveils its first members.